Article

Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication

Harvard University, Cambridge, Massachusetts, United States
Psychological Medicine (Impact Factor: 5.43). 07/2005; 35(7):1073-82. DOI: 10.1017/S0033291705004538
Source: PubMed

ABSTRACT The proposed revisions of the ICD and DSM diagnostic systems have led to increased interest in evaluation of diagnostic criteria. This report focuses on the DSM-IV requirement that episodes of generalized anxiety disorder (GAD) must persist for at least 6 months. Community epidemiological data are used to study the implications of changing this requirement in the range 1-12 months for estimates of prevalence, onset, course, impairment, co-morbidity, associations with parental GAD, and sociodemographic correlates.
Data come from the US National Comorbidity Survey Replication (NCS-R), a US household survey carried out during 2001-2003. Version 3.0 of the WHO Composite International Diagnostic Interview (WMH-CIDI) was used to assess DSM-IV anxiety disorders, mood disorders, substance disorders, and impulse-control disorders.
Lifetime, 12-month, and 30-day prevalence estimates of DSM-IV GAD changed from 6.1%, 2.9%, and 1.8% to 4.2-12.7%, 2.2-5.5%, and 1.6-2.6% when the duration requirement was changed from 6 months to 1-12 months. Cases with episodes of 1-5 months did not differ greatly from those with episodes of > or = 6 months in onset, persistence, impairment, co-morbidity, parental GAD, or sociodemographic correlates.
A large number of people suffer from a GAD-like syndrome with episodes of < 6 months duration. Little basis for excluding these people from a diagnosis is found in the associations examined here.

Full-text

Available from: Dan J. Stein, May 30, 2015
0 Followers
 · 
93 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Previous studies have shown that zinc deficiency and castration could increase anxiety, while
  • [Show abstract] [Hide abstract]
    ABSTRACT: Generalized anxiety disorder (GAD) is a psychological disorder characterized by chronic and severe worry. The past thirty years have seen a surge in the understanding of GAD, and specific advances have been made in how the disorder is conceptualized and treated within the field of psychology. However, despite these advances, GAD remains the most treatment refractory anxiety disorder. The current chapter, therefore, provides an overview of the current conceptualization of GAD, including its key symptoms and features. In addition, this chapter highlights many of the specific theoretical and treatment advances of the past several decades. Finally, this chapter will explore future directions that the field may be able to take in an attempt to better understand and treat this disorder.
    Primer on Anxiety Disorders: Translational Perspectives on Diagnosis and Treatment, 1 edited by Daniel Pine, Barbara Olasov Rothbaum, Kerry Ressler, 03/2015: chapter 22: pages 315-328; Oxford University Press.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the effort on DSM-5 and ICD-11, few appear satisfied with these classification systems. We suggest that the core reason for dissatisfaction is expecting too much from them; they do not provide discrete categories that map to specific causes of disease, they describe clinical syndromes intended to guide treatment choices. Here we review work on anxiety and anxiety disorders to argue that while clinicians draw a pragmatic distinction between normal and abnormal emotions based on considerations such as severity and duration, understanding the evolutionary origins and utility of the emotions, including the adaptive value of adverse emotions, is key for formulating comprehensive assessments of an individual patient’s symptoms and for providing a conceptual foundation for pharmacotherapy, psychotherapy, and public health.
    Emotion Review 01/2015; DOI:10.1177/1754073915575407 · 2.90 Impact Factor